VFEND cpr pell 50 mg 56 pce
7680559460017
CH-55946
J02AC03
08.06.0.
1 / 3
google
Details
- Product number
- 5594601
- CPT
- -
- Packaging group
- 56
- Unit
- Tablette(n)
- Composition
- voriconazolum 50 mg, lactosum monohydricum 62.5 mg, amylum pregelificatum, carmellosum natricum conexum corresp. natrium 1.41 mg, povidonum K 30, magnesii stearas, Überzug: hypromellosum, lactosum monohydricum 0.919 mg, triacetinum, E 171, pro compresso obducto.
Articles (1)
Vfend 50 mg, Filmtabletten
Filmtabletten
56
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
50.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
62.5 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
1.41 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
0.919 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | FNIDK |
Reimbursement information
Public price
CHF 562.40
Specialties list
Yes
Generic
No
SL addition date:
01/05/2003
Authorization holder
Pfizer AG
8052 Zürich
Authorization information
- Swissmedic authorization number
- 55946
- Drug name
- Vfend, Filmtabletten
- Galenic form
- FILM
- ATC Code
- J02AC03
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 29/10/2002
- Authorization expiration date
- 31/12/9999
- IT number
- 08.06.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- VFEND cpr pell 50 mg 56 pce
- Description (DE)
- VFEND Filmtabl 50 mg 56 Stk
- Market launch
- 29/10/2002
- Narcotic (BTM)
- No
Available generics
Voriconazol-Mepha i.v., Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
GTIN:
7680653150029
CHF 161.00
Voriconazol Pfizer, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
GTIN:
7680657700015
CHF 161.00
Voriconazol Pfizer, Pulver zur Herstellung einer Suspension zum Einnehmen
GTIN:
7680657710014
CHF 627.70